Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 2 de 2
1.
J Am Coll Cardiol ; 62(11): 1015-9, 2013 Sep 10.
Article En | MEDLINE | ID: mdl-23747791

OBJECTIVES: This study sought to characterize patients with idiopathic ventricular fibrillation (IVF) who develop electrical storms. BACKGROUND: Some IVF patients develop ventricular fibrillation (VF) storms, but the characteristics of these patients are poorly known. METHODS: Ninety-one IVF patients (86% male) were selected after the exclusion of structural heart diseases, primary electrical diseases, and coronary spasm. Electrocardiogram features were compared between the patients with and without electrical storms. A VF storm was defined as VF occurring ≥3 times in 24 h and J waves >0.1 mV above the isoelectric line in contiguous leads. RESULTS: Fourteen (15.4%) patients had VF storms occurring out-of-hospital at night or in the early morning. J waves were more closely associated with VF storms compared to patients without VF storms: 92.9% versus 36.4% (p < 0.0001). VF storms were controlled by intravenous isoproterenol, which attenuated the J-wave amplitude. After the subsidence of VF storms, the J waves decreased to the nondiagnostic level during the entire follow-up period. Implantable cardioverter-defibrillator therapy was administered to all patients during follow-up. Quinidine therapy was limited, but the patients on disopyramide (n = 3), bepridil (n = 1), or isoprenaline (n = 1) were free from VF recurrence, while VF recurred in 5 of the 9 patients who were not given antiarrhythmic drugs. CONCLUSIONS: The VF storms in the IVF patients were highly associated with J waves that showed augmentation prior to the VF onset. Isoproterenol was effective in controlling VF and attenuated the J waves, which diminished to below the diagnostic level during follow-up. VF recurred in patients followed up without antiarrhythmic agents.


Anti-Arrhythmia Agents/therapeutic use , Defibrillators, Implantable , Electrophysiological Phenomena/physiology , Isoproterenol/therapeutic use , Ventricular Fibrillation/physiopathology , Adolescent , Adult , Electrocardiography , Female , Follow-Up Studies , Humans , Male , Middle Aged , Recurrence , Treatment Outcome , Ventricular Fibrillation/prevention & control , Ventricular Fibrillation/therapy , Young Adult
2.
J Am Coll Cardiol ; 59(22): 1948-53, 2012 May 29.
Article En | MEDLINE | ID: mdl-22624834

OBJECTIVES: This study evaluated the pause-dependency of the J-wave to characterize this phenomenon in idiopathic ventricular fibrillation (VF). BACKGROUND: The J-wave can be found in apparently healthy subjects and in patients at risk for sudden cardiac death, and risk stratification is therefore needed. METHODS: Forty patients with J-wave-associated idiopathic VF were studied for J waves with special reference concerning pause-dependent augmentation. J waves were defined as those ≥0.1 mV above the isoelectric line and were compared with 76 non-VF patients of comparable age and sex. RESULTS: The J-wave was larger in patients with idiopathic VF than in the controls: 0.360 ± 0.181 mV versus 0.192 ± 0.064 mV (p = 0.0011). J waves were augmented during storms of VF (n = 9 [22.5%]), which was controlled by isoproterenol; they disappeared within weeks in 5 patients. In addition, sudden prolongation of the R-R interval was observed in 27 patients induced by benign arrhythmia, and 15 patients (55.6%) demonstrated pause-dependent augmentation (from 0.391 ± 0.126 mV to 0.549 ± 0.220 mV; p < 0.0001). In the other 12 experimental subjects and in the 76 control subjects, J waves remained unchanged. Pause-dependent augmentation of J waves was detected in 55.6% (sensitivity) but was specific (100%) in the patients with idiopathic VF with high positive (100%) and negative (86.4%) predictive values. CONCLUSIONS: Pause-dependent augmentation of J waves was confirmed in about one-half of the patients with idiopathic VF after sudden R-R prolongation. Such dynamicity of J waves was specific to idiopathic VF and may be used for risk stratification.


Death, Sudden, Cardiac/epidemiology , Electrocardiography , Isoproterenol/therapeutic use , Ventricular Fibrillation/physiopathology , Adrenergic beta-Agonists/therapeutic use , Adult , Death, Sudden, Cardiac/prevention & control , Female , Follow-Up Studies , Humans , Incidence , Japan/epidemiology , Male , Predictive Value of Tests , Prognosis , Retrospective Studies , Risk Factors , Survival Rate/trends , Ventricular Fibrillation/drug therapy , Ventricular Fibrillation/mortality
...